Misplaced trust? The recent ranitidine recall is leaving patients with a bad case of heartburn
Recently, both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) recommended precautionary measures due...
Contributors
-
Account Manager -
Associate Consultant -
President, USA -
-
Publications Executive -
Project Director -
Associate Consultant -
Consultant -
Consultant -
Senior Consultant -
SVP -
Master Practitioner: Patient Insights -
Publications Assistant -
EVP, Oncology Practice Head -
-
Chief Commercial Officer -
US CEO -
Account Manager -
Senior Consultant -
Associate Editorial Director -
Sr. Research Analyst -
Associate Consultant -
Principal -
Research Executive -
Account Director -
Consultant -
Vice President -
Head of MedErgy (CH-MedErgy) -
Marketing and Communications Manager -
Project Manager -
Project Manager -
Managing Consultant -
Senior Consultant -
Project Director -
Executive Vice President, Strategic Collaborations -
Associate Consultant
Cello Health Archive
- January 2020 (4)
- December 2019 (3)
- November 2019 (4)
- October 2019 (1)
- September 2019 (2)
- August 2019 (4)
- July 2019 (4)
- June 2019 (4)
- May 2019 (12)
- April 2019 (11)
- March 2019 (5)
- February 2019 (12)
- January 2019 (1)
- October 2018 (2)
- August 2018 (5)
- July 2018 (7)
- June 2018 (5)
- May 2018 (5)
- April 2018 (6)
- March 2018 (9)
- February 2018 (11)
- January 2018 (4)
- December 2017 (8)
- November 2017 (21)
- October 2017 (35)
- September 2017 (18)
- August 2017 (1)
- July 2017 (1)
- June 2017 (1)
- May 2017 (2)
- April 2017 (2)
- March 2017 (1)
- February 2017 (2)
- January 2017 (1)
- December 2016 (1)
- October 2016 (1)
How best to increase public awareness of antibiotic resistance?
Timed to coincide with World Antibiotic Awareness Week (WAAW), BMJ Opinion recently published a thought-provoking article outlining key...
Lyme Disease, one small step in the right direction.
It's great to see that Lyme Disease research continues to be picked up by the scientific media. Having seen first hand the devastating...
Flipping the traditional drug development model on its head; Custom-designed CRISPR therapy is close to becoming a reality
Rich Horgan, the founder of the nonprofit Cure Rare Disease, is on a quest to develop a therapy for his brother Terry who was born with...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net